Close

Actinium Pharmaceuticals, Inc. Announces Closing of $25.0 Million Public Offering Jun 19, 2020 05:15PM
Actinium Pharmaceuticals, Inc. Announces Closing of $31.6 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares Apr 24, 2020 05:15PM
Novartis' Deal for Endocyte Creates 'Scarcity Value' for Actinium Pharma (ATNM) - Maxim Oct 18, 2018 01:17PM
Actinium Announces $15.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering Mar 5, 2018 07:30AM
Actinium Pharmaceuticals Reiterates Previously Announced Expiration Date of March 2, 2018 at 5:00 PM ET and Amendment to Pricing Terms of its Rights Offering Feb 26, 2018 09:53AM


Feb 22, 2018 07:30AM Actinium Pharmaceuticals Announces Commencement of Rights Offering Subscription Period
Feb 12, 2018 07:30AM Actinium Pharmaceuticals Reminds Investors of Today’s Deadline to be a Shareholder of Record
Feb 7, 2018 09:00AM Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering
Feb 1, 2018 04:39PM Actinium Pharma (ATNM) Announces Rights Offering
Feb 1, 2018 04:05PM Actinium Pharmaceuticals Announces Rights Offering
Oct 4, 2017 10:17AM Maxim Group Maintains Bullish View on Actinium Pharma (ATNM) as Phase II Trial Ramps Up
Sep 14, 2017 09:20AM Pre-Open Movers 09/14: (HALO) (THC) (ALV) Higher; (ARRY) (HTZ) (VNDA) Lower (more...)
Sep 14, 2017 07:45AM UPDATE: Maxim Group Starts Actinium Pharma (ATNM) at Buy
Aug 2, 2017 04:05PM Actinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock
Jul 28, 2017 09:10AM Actinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock